NASDAQ$MDLN
Medline Inc · Q1 2026 earnings
Q1 2026 earnings ·
Briefing
Medline Inc Q1 fiscal 2026: $7.35B revenue, $239.0M net income
for the year ended December 31, 2025 (the “2025 Form 10-K”). (SEC accession 0002046386-26-000026)
- Revenue: $7.35B
- Net income: $239.0M
- Diluted EPS: $0.16
- Operating income: $422.0M
- Gross profit: $1.84B
Headline financials
Revenue & EPS history
Medline Inc · Revenue · Quarterly
$7.35B
Q1 2026
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 1 quarterly earnings reports · overlaid with Q1 2026
-5.5%
Avg return
Earnings day
-10.8%
Avg return
5 days after
-17.3%
Avg return
30 days after
0%
0 / 2 earnings
Positive
-3.6%
Q4 2025
Best reaction
-7.3%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -7.3% | -13.4% | — | |
| Q4 2025 | -3.6% | -8.3% | -17.3% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro